All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ACRIVON THERAPEUTICS, INC. Last Reported: 4/30/2024 Stock Symbol: ACRV

Business Address

480 ARSENAL WAY, SUITE 100

WATERTOWN , MA US 02472

Mailing Address

480 ARSENAL WAY, SUITE 100

WATERTOWN , MA US 02472
Phone Number: 617-207-8979 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020
Cash and Cash Equivalents $36,015,000.00 $29,859,000.00 $38,074,000.00 $29,519,000.00 $32,080,000.00 -- -- $99,603,000.00 $3,614,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $2,234,000.00 $2,402,000.00 $2,328,000.00 $4,344,000.00 $1,849,000.00 -- -- $805,000.00 -- -- -- --
Total Current Assets $129,692,000.00 $144,492,000.00 $153,282,000.00 $132,095,000.00 $78,672,000.00 -- -- $100,408,000.00 -- -- -- --
Property Plant and Equipement $3,479,000.00 $2,003,000.00 $1,975,000.00 $2,092,000.00 $2,151,000.00 -- -- $290,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $138,265,000.00 $151,092,000.00 $160,049,000.00 $181,226,000.00 $87,713,000.00 -- -- $106,587,000.00 -- -- -- --
Accounts Payable $5,048,000.00 $1,504,000.00 $1,267,000.00 $904,000.00 $1,976,000.00 -- -- $964,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $17,070,000.00 $12,943,000.00 $10,865,000.00 $10,751,000.00 $10,811,000.00 -- -- $7,878,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-83,000.00 $-302,000.00 $-427,000.00 $-95,000.00 $-133,000.00 -- -- -- -- -- -- --
Accumulated Deficit $-116,420,000.00 $-97,168,000.00 $-82,700,000.00 $-56,000,000.00 $-47,100,000.00 -- -- $-24,865,000.00 -- -- -- --
Total Stockholders' Equity $121,195,000.00 $138,149,000.00 $149,184,000.00 $170,475,000.00 $-45,616,000.00 $-36,576,000.00 $-30,989,000.00 $-23,809,000.00 $-19,770,000.00 $-17,358,000.00 $-14,837,000.00 $-8,413,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $138,265,000.00 $151,092,000.00 $160,049,000.00 $181,226,000.00 $87,713,000.00 -- -- $106,587,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020
Total Revenues -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $46,024,000.00 -- -- -- -- -- -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $67,103,000.00 $46,050,000.00 $15,520,000.00 $32,657,000.00 $9,575,000.00 -- -- -- $2,671,000.00 -- -- --
Loss from Operations $-67,103,000.00 $-46,050,000.00 $-15,520,000.00 $-32,657,000.00 $-22,712,000.00 -- -- -- $-11,914,000.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-2.74 $-1.87 $-1.22 $-7.56 $-5.17 -- -- -- $-6.86 -- -- --
Weighted Average Shares Basic 22,078,190 21,991,509 21,971,032 4,121,912 1,778,255 -- -- -- 1,734,560 -- -- --
Earnings Per Share Diluted $-2.74 $-1.87 $-0.63 $-7.56 $-12.55 -- -- -- $-6.86 -- -- --
Weighted Average Shares Diluted 22,078,190 21,991,509 21,971,032 4,121,912 1,778,255 -- -- -- 1,769,132 -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 40,013,683 -- -- 40,013,683 -- -- -- --
Common Stock Shares Outstanding 22,522,644 22,104,469 22,068,660 21,920,402 1,794,600 -- -- 1,769,561 -- -- -- --
Common Stock Value $23,000.00 $22,000.00 $22,000.00 $22,000.00 $2,000.00 -- -- $2,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com